Search

everythinglearnresearchcommunity

for

Search:↓

A mutation in the human hairless gene causes alopecia universalis.

Topical cyclosporine lotion led to hair regrowth in a man with alopecia universalis.

Azathioprine treatment led to rapid hair regrowth in a woman with alopecia universalis.

Topical cyclosporine lotion led to noticeable hair regrowth in alopecia universalis.

Alopecia areata is an autoimmune disease causing hair loss, linked to immune and gut issues, needing more research for better treatments.

Finasteride may help postmenopausal women with hair loss but is not effective for all and should be used cautiously in premenopausal women.

Elderly patients often have skin issues like itching and hair loss, and early treatment can improve their quality of life.

Use 5% minoxidil or oral finasteride for mild-to-moderate hair loss, combine with hair transplant for severe cases.

Managing multiple autoimmune diseases in one patient is extremely challenging.

PRP might help with hair growth, but its effectiveness in hair transplants is unclear.

Some plants may help with hair growth but need more scientific evidence.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Azelaic acid's effectiveness in treating certain skin conditions needs more research.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Abrocitinib may effectively treat stubborn alopecia universalis.

The conclusion is that a safe donor area for hair transplants varies and should be chosen based on individual factors like race, future hair loss, family history, and specific thinning patterns.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

Mogamulizumab can cause hair loss and skin rashes.

JAK inhibitors and combination therapies show promise for treating severe alopecia areata.

Alopecia areata treatments include immune inhibitors, topical sensitizers, irritants, and minoxidil, with future focus on immunosuppressive approaches.

Alopecia areata treatment varies, with no optimal method established yet.

Allergen desensitization reduces hair loss severity in dust-mite allergic alopecia areata patients.

Androgens contribute to common male hair loss; more research needed for hair growth medication.

Most patients with autoimmune blistering diseases experienced some hair loss, which may be underreported and linked to disease severity.

Scalp biopsies from dermatomyositis patients show chronic hair loss without scarring, with mucin and blood vessel changes being very common.

The guideline provides recommendations for managing alopecia areata effectively.

COVID-19 doesn't make alopecia areata worse.

Alopecia areata is often linked to personal or family history of allergies and autoimmune diseases.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.